# An Open-label, Single-Arm Study to Evaluate the Safety and Rabies Virus Antibody Titers of Intramuscularly Administered Rabies Immune Globulin (Human)

> **NCT02139657** · PHASE1 · COMPLETED · sponsor: **Grifols Therapeutics LLC** · enrollment: 12 (actual)

## Conditions studied

- Rabies

## Interventions

- **BIOLOGICAL:** RIG-C

## Key facts

- **NCT ID:** NCT02139657
- **Lead sponsor:** Grifols Therapeutics LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-03
- **Primary completion:** 2014-05
- **Final completion:** 2014-05
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2014-07-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02139657

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02139657, "An Open-label, Single-Arm Study to Evaluate the Safety and Rabies Virus Antibody Titers of Intramuscularly Administered Rabies Immune Globulin (Human)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02139657. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*